2nd North American LVV US workshop.
✔️improvement of Halo sign ➡️ more rapid in temporal than in axillary arteries.
✔️Patients with GCA-LVV: worse outcomes #MayoClinicRheumatology.
✔️Lots of great hand on practice.
@USSONAR_Rh@MdWarrington@UWRheum
Dr Koster @MdWarrington@AliDuarteMD open label study baricitinib in relapsing GCA. Well-tolerated and allowed GC discontinuation by 24 weeks in most patients. Encouraging, we need an RCT! Abstr#1396 #ACR21@RheumNow
✔️If suspected Strongyloides and unable to test serologies: Empiric treatment with 2 days of ivermectin.
✔️Highlited the Importance of CAP CT scan if unclear etiology (could help Dx malignancy, IgG4)
Excellent presentation by Dr. Amy Klion in a very challenging topic @NIH#ACR21
#Hypereosinophilic syndromes, tips from #ACR21:
✔️Rule out: Parasites (Strongyloides), drug hypersensitivity, malignancy, EGPA
✔️BM Biopsy: Anyone with an elevated B12, tryptase, splenomegaly
✔️Be watchful of those nonsteroids responsive
Happening now at #ACR21!
Dr. Bryant England discussing multimorbidity in RA as part of the community hub!
- We need to understand how a patient is feeling overall (due to their other conditions)
- How we treat is impacted by their other medical conditions
#ACRAmbassador
Great talk on #GCA by @anisha_dua
Thanks for highlighting the '2nd biopsy' study from @MayoClinic
44% of TAB still positive after 12 months of glucocorticoids
#vasculitis
Happening right now at #ACR21! Radiology Boot Camp. Remarkable teaching by Dr. Linchtenberger on lung manifestations in rheumatic diseases: Atoll Sign. I also want to go to the Maldives! @ACRheum
En breve iniciamos participación en #ACR21 con la perspectiva @PanlarLeague@PanlarJ del futuro de la reumatología.
Una discusión que estará interesante.